Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Estrogen as neuroprotectant of nigrostriatal dopaminergic system: laboratory and clinical studies.

Dluzen D, Horstink M.

Endocrine. 2003 Jun;21(1):67-75. Review.

PMID:
12777705
3.

Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease.

Liu B, Dluzen DE.

Clin Exp Pharmacol Physiol. 2007 Jul;34(7):555-65. Review.

PMID:
17581209
4.

Estrogen and the development and protection of nigrostriatal dopaminergic neurons: concerted action of a multitude of signals, protective molecules, and growth factors.

Kipp M, Karakaya S, Pawlak J, Araujo-Wright G, Arnold S, Beyer C.

Front Neuroendocrinol. 2006 Dec;27(4):376-90. Review.

PMID:
16949139
6.

Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system.

Dluzen DE.

J Neurocytol. 2000 May-Jun;29(5-6):387-99. Review.

PMID:
11424955
7.

Gender differences in neurotoxicity of the nigrostriatal dopaminergic system: implications for Parkinson's disease.

Dluzen DE, McDermott JL.

J Gend Specif Med. 2000 Sep-Oct;3(6):36-42. Review.

PMID:
11253381
8.

Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system.

Gajjar TM, Anderson LI, Dluzen DE.

J Neural Transm (Vienna). 2003 Nov;110(11):1215-24.

PMID:
14628187
9.
10.
13.

GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged parkinsonian mice.

Date I, Aoi M, Tomita S, Collins F, Ohmoto T.

Neuroreport. 1998 Jul 13;9(10):2365-9.

PMID:
9694229
14.

Evaluation of estrogen neuroprotective effect on nigrostriatal dopaminergic neurons following 6-hydroxydopamine injection into the substantia nigra pars compacta or the medial forebrain bundle.

Ferraz AC, Matheussi F, Szawka RE, Rizelio V, Delattre AM, Rigon P, Hermel Edo E, Xavier LL, Achaval M, Anselmo-Franci JA.

Neurochem Res. 2008 Jul;33(7):1238-46. doi: 10.1007/s11064-007-9575-7.

PMID:
18259859
15.
16.

Adult neurogenesis and Parkinson's disease.

Arias-Carrión O, Freundlieb N, Oertel WH, Höglinger GU.

CNS Neurol Disord Drug Targets. 2007 Oct;6(5):326-35. Review.

PMID:
18045161
19.

FGF-2 deficiency does not alter vulnerability of the dopaminergic nigrostriatal system towards MPTP intoxication in mice.

Zechel S, Jarosik J, Kiprianova I, Schober A, Unsicker K, von Bohlen und Halbach O.

Eur J Neurosci. 2006 Mar;23(6):1671-5.

PMID:
16553632
20.

Manganese: a transition metal protects nigrostriatal neurons from oxidative stress in the iron-induced animal model of parkinsonism.

Sziráki I, Mohanakumar KP, Rauhala P, Kim HG, Yeh KJ, Chiueh CC.

Neuroscience. 1998 Aug;85(4):1101-11.

PMID:
9681949

Supplemental Content

Support Center